Analysis Group is one of the largest international economics consulting firms, with more than 950 professionals across 14 offices in North America, Europe, and Asia. Since 1981, we have provided expertise in economics, finance, health care analytics, and strategy to top law firms, Fortune Global 500 companies, and government agencies worldwide. Our internal experts, together with our network of affiliated experts from academia, industry, and government, offer our clients exceptional breadth and depth of expertise.
The FTC is a bipartisan federal agency with a unique dual mission to protect consumers and promote competition. For one hundred years, our collegial and consensus-driven agency has championed the interests of American consumers. As we begin our second century, the FTC is dedicated to advancing consumer interests while encouraging innovation and competition in our dynamic economy.
Ms. Wong has over a decade of experience applying economic consulting expertise in a variety of litigation matters involving securities, accounting, antitrust, corporate governance, pharmaceutical reverse payments, off-label pharmaceutical marketing, and intellectual property and trade secrets. These cases have spanned a range of industries, including health care, telecommunications, entertainment media, finance, software, real estate, and manufacturing. Ms. Wong has supported experts and attorneys in many aspects of litigation, including assisting with preparation of complex expert reports by prominent academic affiliates, performing econometric and statistical analyses, preparing experts for testimony, consulting throughout the discovery process, and assisting attorneys with cross-examination of opposing experts. Ms. Wong received her M.B.A. from the MIT Sloan School of Management and her A.B. in economics from Harvard University.
Jordy Hur is an attorney in the Health Care Division of the Federal Trade Commission’s Bureau of Competition in Washington, D.C. She investigates alleged violations of the antitrust law by pharmaceutical companies, physicians and other health professionals, and hospitals and institutional providers. Jordy has also been involved in multiple federal court litigations challenging anticompetitive practices in the pharmaceutical industry, including reverse payment litigations.